This stock looks to be breaking out through a triple top formation ... La Jolla Pharmaceuticals (NASDAQ: LJPC) is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies …
La Jolla Pharmaceutical Company (Nasdaq: LJPC) ("La Jolla" or the "Company"), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, …
LJPC-501 successfully increased the proportion of patients achieving ... 10 stocks we like better than La Jolla Pharmaceutical When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the …
La Jolla Pharmaceutical Company LJPC was a big mover last session, as the company saw its shares rise over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This …
LONDON, UK / ACCESSWIRE / September 27, 2017 / Pro-Trader Daily looks at the latest corporate events and news …
After announcing that its phase 3 ATHOS-3 study would be published in a prestigious medical journal, clinical-stage biotech La Jolla Pharmaceutical (NASDAQ: LJPC) saw its shares ... David and Tom Gardner have a stock tip, it can …
La Jolla Pharmaceutical Company (NASDAQ: LJPC) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at LJPC
LJPC-501 successfully increased the proportion of patients achieving ... When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock